Восени у Вільнюсі відбудеться захід для стартапів „Life Sciences Baltics“
„Life Sciences Baltics“ - це найбільший у країнах Балтії захід для стартапів у сфері наук про життя. У вересні експерти з біотехнології, фармацевтики, медицини зберуться у Вільнюсі для обговорення актуальних питань, обміну досвідом і відкриття нових можливостей для співпраці.
Більше інформації про захід: www.lsb2018.com
This September, some 1,500 world class biotechnology, pharmaceutical and medical devices experts will descend in Vilnius, Lithuania, for Life Sciences Baltics, the only international forum in the Baltic countries that provides a unique opportunity to explore new horizons of partnerships, exchange ideas and seek progress through networking. The Baltic countries comes into the spotlight to reveal their potential in the field of life sciences.
Why Lithuania? Lithuania hosts one of the most innovative science hubs in Europe: 16 academic institutions, 16 most competent open access research and development centres along with the pool of over 15,000 specialists and researchers as well as nearly 300 companies operating in the sector, science parks, and innovation valleys. The confluence of scientific and business power builds the right platform to succeed in becoming one of the top high tech innovation centres in Europe.
Lithuania is among world leaders for research and development personnel per capita, and the number of various start-ups and small-to-medium enterprises constantly grows. Numerous discoveries position Lithuania on the map of ambitious scientific endeavours.
The Cas9-protein technology that functions like scissors for cleaving DNA molecules has advanced rapidly and is considered a breakthrough because of its huge potential in future applications, already noticed by the global business. Lithuanian scientist prof. Virginijus Šikšnys is one of the researchers who have contributed to the discovery of this scissor-tool.
A nation with a population of only 3 million is among the top EU countries by percentage of specialists with higher education. 8% of all students are enrolled in biology, chemistry, pharmacy, physics, medicine, diagnostics and medical technologies.
Around 60 speakers will present their topics at Life Sciences Baltics that is going to be held on September 26-27. Brian K. Kobilka, the recipient of the 2012 Nobel Prize in Chemistry for his work on G-protein-coupled receptors, will be the keynote speaker at the conference.
The conference is divided into 12 sessions about the most significant trends that shape life sciences industry. The first day of the conference will feature sessions on the mechanics of genetic diseases, challenges of immune-oncology treatment, 3D printing in medicine, the role of personalized medicine, digital health. The topics of the second day include laser applications, stem cells and research as the impulse for the industry.
Apart from the conference, Life Sciences Baltics 2018 participants will be able to explore an exhibition with more 60 companies from Germany, Italy, Estonia, Latvia and other countries; participate in B2B meetings and witness the pitches of up to 30 invest ready life sciences startups from the Baltic countries.
Organised by Enterprise Lithuania, the Life Sciences Baltics is the biannual event enabling life sciences sector leaders, government officials and other from around the world to see the rapidly growing life sciences scene in the Baltics.
More information about Life Sciences Baltics 2018: www.lsb2018.com